Indication

Complicated E. coli peritonitis

Complicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity. Read more about Complicated E. coli peritonitis

103 drugs 69 manufacturers

Advertisement

Drugs that treat it

Common Complicated E. coli peritonitis therapies.

Showing 28–36 of 103 drugs

CEFEPIME HCL

BETA-LACTAMS·FEBRILE NEUTROPENIC PATIENT PRESUMED INFECTION TREATMENT·+26
WG CRITICAL CAR
Filter & compare in the drug finder →Opens the drug finder with Complicated E. coli peritonitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complicated E. coli peritonitis.

Complicated *Escherichia coli* peritonitis is a severe, pathogen-specific intra-abdominal infection characterized by inflammation of the peritoneum that extends beyond a localized hollow viscus into the peritoneal cavity.

Most commonly arising as secondary peritonitis from gastrointestinal perforation, anastomotic leak, or as an advanced complication of peritoneal dialysis and end-stage liver disease, it directly affects the gastrointestinal and peritoneal systems.

Pathophysiologically, disruption of anatomical barriers or transmural bacterial translocation allows virulent *E.

coli* to inoculate the peritoneal space, triggering intense neutrophilic exudation, abscess formation, and systemic endotoxemia.

Clinically, it presents with severe abdominal pain, diffuse guarding or rigidity, fever, and leukocytosis, frequently progressing to systemic inflammatory response syndrome, sepsis, or septic shock without prompt surgical source control and directed antimicrobial therapy.

Personalize your experience

Follow Complicated E. coli peritonitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it